ENBI — Entheon Biomedical Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Entheon Biomedical, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.

	2020 March 31st	2021 November 30th	2022 November 30th	2023 November 30th	2024 November 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0.022	0.19	0.25	0
Cost of Revenue
Gross Profit	—	0.009	—	—	—
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	0.167	9.13	3.79	0.563	0.333
Operating Profit	-0.167	-9.11	-3.6	-0.313	-0.333
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.147	-8.89	-2.06	-0.3	-0.318
Provision for Income Taxes
Net Income After Taxes	-0.147	-8.89	-2.06	-0.3	-0.318
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.147	-8.89	-8.52	-0.3	-0.318
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.147	-8.89	-8.52	-0.3	-0.318
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.243	-1.64	-0.575	-0.051	-0.041